From Yahoo Finance: 2025-05-08 08:22:00

Kenvue’s stock rose in premarket trading after reporting first-quarter results exceeding analyst expectations. The consumer products maker, formerly part of Johnson & Johnson, posted adjusted EPS of $0.24 on net sales of $3.74 billion. It anticipates 2025 sales growth of 1-3%, despite a projected decline in adjusted operating income margin due to tariffs. Amit Banati will become CFO next week. Kenvue shares were up 5% before the market opened.

Read more: Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Sales Outlook